Bilbo: Udako Euskal Unibertsitatea, 2010. — 208 orr. — ISBN 978-84-8438-286-7. Eskuliburu teoriko-praktiko honen helburua da alzheimer dementzia motari buruz lehen hurbilketa orokorra egitea. Zazpi atal nagusi ditu eta bakoitzak hainbat azpiatal. Guztien amaieran, egitura bera baliatu da: batetik, gaiarekin erlazioa duten ariketa praktikoak prestatu dira irakurleak aztergai...
Springer, 2021. — 315 p. — ISBN 978-981-16-4557-0. This book talks about the multidimensional biological etiology of Alzheimer’s disease and autism spectrum disorder which leads to distinctive ways of perception, thinking and learning in affected individuals. It provides a deeper emphasis on the need for early diagnosis, continuous assessment of patients and the proper...
Springer, 2021. — 921 p. — ISBN 978-981-16-4558-7. This book talks about the multidimensional biological etiology of Alzheimer’s disease and autism spectrum disorder which leads to distinctive ways of perception, thinking and learning in affected individuals. It provides a deeper emphasis on the need for early diagnosis, continuous assessment of patients and the proper...
IMedPub, 2013. — 136 p. In view of the growing prevalence of AD worldwide, there is an urgent need for the development of better diagnostic tools and more effective therapeutic interventions. Indeed, much work in this field has been done during last decades. As such, a major goal of current clinical research in AD is to improve early detection of disease and presymptomatic...
Springer-Verlag London, 2007. — 298 p.
Abeta Peptide and Alzheimer’s Disease summarizes current knowledge of beta-amyloid peptide (Aß) and its role as the major culprit in Alzheimer’s Disease (AD), shown by recent advances in genetics and brain biochemistry.
Written by leaders in the industrial and academic world specializing in this rapidly moving area, the book covers...
Century, 2024. — 288 p. Think your brain healthy with these fun puzzles from the UK Alzheimer’s SocietyThe key to a healthy life is having a healthy mind. Dementia can’t be cured, but we can work to help prevent it with simple changes to our lifestyles. Research shows that people who have mentally stimulating jobs or hobbies – such as puzzles and crosswords – have better brain...
Century, 2024. — 288 p. Think your brain healthy with these fun puzzles from the UK Alzheimer’s SocietyThe key to a healthy life is having a healthy mind. Dementia can’t be cured, but we can work to help prevent it with simple changes to our lifestyles. Research shows that people who have mentally stimulating jobs or hobbies – such as puzzles and crosswords – have better brain...
Springer, 2023. — 661 p. This book highlights the key phases and central findings of Alzheimer’s Disease research since the introduction of the label ‘Alzheimer’s Disease’ in 1910. The author, Christian Behl, puts dementia research in the context of the respective zeitgeist and summarizes the paths that have led to the currently available Alzheimer’s drugs. As the reader is...
New York: Omnigraphics Inc., 2011. — 657 p. — ISBN 978-0-7808-1150-8. Basic Consumer Health Information About Alzheimer's Disease, Related Disorders, and Other Dementias (Health Reference Series, Vol 46) Library Binding – February 1, 1999 Alzheimer's disease or a related disorder afflict only five to six percent of older people, but this means approximately three to four...
Academic Press, 2021. — 486 p. — ISBN 978-0-12-819212-2. Naturally Occurring Chemicals against Alzheimer’s Disease offers a detailed discussion on the roles, molecular mechanisms, structural activity relationships, toxicology and clinical data on phytochemicals in relation to Alzheimer’s disease. The book examines the available phytochemicals and plants that are potentially...
Boca Raton: CRC Press, 2024. — 210 p. This reference book compiles the recent advances in computational and experimental modelling to screen and manage Alzheimer’s disease. It covers basic etiopathology and various in vitro and in vivo strategies of disease intervention. The book discusses how computer-aided drug design approaches reduce costs and increase biological test...
Chelsea House Publishers, 2006. — 96 p. — (Drugs. The Straight Facts). Alzheimer's disease (AD) and other forms of dementia affect more people than ever before. Researchers are studying new drugs that have been designed to treat and prevent age-related dementia, and even improve the memories of people of all ages. Alzheimer s Disease and Memory Drugs covers the history of AD,...
Nova Science Publishers, 2011. — 307 p. — (Neurology- Laboratory and Clinical Research Developments). — ISBN 978-1611220643. Dementia is a brain disorder that seriously affects a person's ability to carry out daily activities. The most common form of dementia among older people is Alzheimer's Disease (AD), which involves the parts of the brain that control thought, memory, and...
5th Ed. — Purdue University Press, 2016. — 265 p. — ASIN B01NCLB1J7, ISBN: 1557537607. The beloved best seller has been revised and expanded for the fifth edition. Jolene Brackey has a vision: that we will soon look beyond the challenges of Alzheimer's disease to focus more of our energies on creating moments of joy. When people have short-term memory loss, their lives are made...
4th edition. — Purdue University Press, 2007. — 331 p. Jolene Brackey has a vision. A vision that will soon look beyond the challenges of Alzheimer's disease and focus more of our energy on creating moments of joy. When a person has short-term memory loss, his life is made up of moments. But if you think about it, our memory is made up of moments, too. We are not able to create a...
Springer, 2020. — 348 p. — (Human-Computer Interaction Series). — ISBN: 978-3-030-32834-4. Old age is currently the greatest risk factor for developing dementia. Since older people make up a larger portion of the population than ever before, the resulting increase in the incidence of dementia presents a major challenge for society. Dementia is complex and multifaceted and...
Penguin Random House, 2017. — 308 p. The instant New York Times and Wall Street Journal bestseller A groundbreaking plan to prevent and reverse Alzheimer's Disease that fundamentally changes how we understand cognitive decline. Everyone knows someone who has survived cancer, but until now no one knows anyone who has survived Alzheimer's Disease. In this paradigm shifting book,...
Wiley-Blackwell, 2011. — 664 p. — ISBN: 978-1-405-16828-1. This is a broad-ranging review of the current research on Alzheimer's disease and other dementias from both basic neuroscience and clinical perspectives. It provides scientists and medical professionals with an extensive introduction and an up-to-date review of cutting-edge scientific advances. This reference begins...
2nd edition. — Elsevier, 2016. — 283 p. — ISBN: 978-0-323-28661-9 Now presented in full color, this updated edition of Memory Loss, Alzheimer's Disease, and Dementia is designed as a practical guide for clinicians that delivers the latest treatment approaches and research findings for dementia and related illnesses. Drs. Budson and Solomon — both key leaders in the field —...
Elsevier, 2018. — 186 p. — ISBN: 978-0-323-54425-2. Get a thorough, expert overview of the many key facets of chronic traumatic encephalopathy (CTE) with this concise, practical resource by Drs. Andrew E. Budson, Ann C. McKee, Robert C. Cantu, and Robert A. Stern. This easy-to-read reference is based on lectures from Boston University’s Alzheimer’s Disease Center’s November 2016...
ITexLi, 2023. — 289 p. — ISBN 1837683433 9781837683437 1837683425 9781837683420 1837683441 9781837683444. This book offers innovative constructs of knowledge and reasoning on autistic pathology according to the perspectives offered by functional neuroscience and neuroimaging data and considers new etiological perspectives and therapeutic strategies centered on the child and the...
Humana Press, 2016. — 581 p. Alzheimer’s disease (AD) and many other neurodegenerative disorders are multifactorial in nature, involving a combination of genomic, epigenomic, network dynamic and environmental factors. A proper investigation requires new integrative Systems Biology approaches, at both the experimental and computational level. The interplay of disease mechanisms and...
Springer, 1992. — 165 p. Any mention of the relationship, still poorly understood, between body (or brain) and mind invariably invokes the name of Descartes, who is often thought of as the father of modern philosophy and perhaps of neurophilosophy. Although a native of the heart of France (the region around Tours), Rene Descartes travelled widely, as everyone knows, especially...
Springer, 2023. — 461 p. This volume explores the latest techniques used to study the human brain towards understanding Alzheimer’s Disease and related neurodegenerative disorders. Contributed to by world-renowned experts, the chapters in this book are divided into five parts. Part One discusses human post-mortem brain preparations including single-cell isolation and use of...
CRC Press, 2003. — 179 p. Beta-secretase. M. Citron Alpha-secretases. S. Ishiura ADAM 10/alpha secretase and presenilins/gamma secretase in APP processing and notch signaling. D. Hartmann Gamma-secretase and presenilin. M. Wolfe Biochemistry of gamma-secretase (tentative title). S. Sinha Presenilin and intracellular protein transport Degradation of Abeta by neprilysin. T.C. Saido...
Wiley-ISTE, 2021. — 184 p. — (Cognitive Science Series). — ISBN 978-1-78630-662-3. This book questions the relationship and compatibility between current beliefs in neurology and contemporary textual linguistic theories, interpretative semantics and discourse analysis.It begins with a critical examination of the screenings for Alzheimer’s type dementia through cognitive...
Elsevier, 2016. — 207 p. Consequences of Intracellular Amyloid in Alzheimer’s Disease addresses one of the more currently unresolved aspects confounding Alzheimer’s research, the significance of intraneuronal amyloid. It seeks to explain some of the unresolved questions concerning intracellular amyloid and its origin, entry, and toxicity. Following up on Dr. D’Andrea’s first...
First Interact, 2009. — 332 p. ISBN: 2754010580. Книга на французском языке. - L'ouvrage La maladie d'Alzheimer pour les Nuls présente cette maladie neurodégénérative du tissu cérébral à tous ceux qui voudraient en savoir plus. Proches des malades, personnel soignant, membres de la famille y trouveront de nombreuses réponses, pour accompagner et comprendre le malade au...
Nova Science Publishers, Incorporated, 2017. — 305 p. The brain is an extremely complex organ that defines your uniqueness. As you age, though, your brain may be susceptible to a terrible disease. Alzheimer's disease is the third biggest killer in the developed world after cancer and heart disease. It is considered an irreversible, progressive brain disorder that slowly erases...
Informa Healthcare, 2007. — 159 p. — ISBN: 978 0 415 39045 3 The last 20 years have brought unprecedented new knowledge to our understanding of Alzheimer's disease (AD) and for the first time, approved symptomatic treatments. Authored by one of the world's leading authorities on the management of AD and related dementias, this highly illustrated Atlas of Alzheimer’s Disease...
Academic Press, 2021. — 514 p. — ISBN 978-0-12-819344-0. Sex and Gender Differences in Alzheimer’s Disease: The Women’s Brain Project offers for the first time a critical overview of the evidence documenting sex and gender differences in Alzheimer’s disease neurobiology, biomarkers, clinical presentation, treatment, clinical trials and their outcomes, and socioeconomic impact...
Nova Biomedical , 2008. — 318 p. — ISBN: 978-1604569919 Alzheimer's disease (AD) is characterized by the deposition into the brain of amyloid peptide, which originates a cascade of inflammatory events leading eventually to neuronal death. This book gives information about MCI as prodromal Alzheimer's disease (AD), and discusses the main known pathological mechanisms at the...
Royal Society of Chemistry, 2022. — 694 p. — ISBN 978-1-83916-230-5. Alzheimer’s disease is an increasingly common form of dementia and despite rising interest in discovery of novel treatments and investigation into aetiology, there are no currently approved treatments that directly tackle the causes of the condition. Due to its multifactorial pathogenesis, current treatments...
Royal Society of Chemistry, 2022. — 1704 p. — ISBN 978-1-83916-274-9. Alzheimer’s disease is an increasingly common form of dementia and despite rising interest in discovery of novel treatments and investigation into aetiology, there are no currently approved treatments that directly tackle the causes of the condition. Due to its multifactorial pathogenesis, current treatments...
Nova Science Publishers, 2016. — 115 p. — (Neurology – Laboratory and Clinical Research Developments) — ISBN: 978-1-63484-032-3 Alzheimer’s disease (AD) is the most common form of senile dementia worldwide. Anosognosia, a deficit in self-awareness, is recognized as one of the core symptoms of Alzheimer’s disease dementia, in which self-awareness gradually deteriorates with...
Simon & Schuster, 2017. — 296 p. — ISBN10: 1451697228. — ISBN13: 978-1451697223. An inspiring race against time: The courageous, hopeful story of the one family who may hold the key to finding a cure for Alzheimer's disease. Every sixty-nine seconds, someone is diagnosed with Alzheimer's disease. Of the top ten killers, it is the only disease for which there is no cure or...
Springer, 2025. — 283 p. — ISBN-13 : 978-3031849190 This volume brings together pre-clinical and clinical research on topics highly relevant to the development and improvement of our understanding of Alzheimer’s disease (AD). The combination of both research areas will appeal to a broad range of researchers from basic scientists to neurologists. The topics cover both...
World Scientific Publishing, 2022. — 408 p. — ISBN 9781800610118. Alzheimer's disease (AD) is the leading cause of dementia and, unfortunately, remains incurable. The social, emotional and financial implications of AD are immeasurable, and about 47 million people worldwide are affected by AD or other forms of dementia. As lifespans are improved by healthcare systems worldwide,...
Academic Press, 2018. — 103 p. — ISBN: 978-0-12-815392-5. This book provides a practical and easy-to-use guide for researchers in EEG signal processing techniques, Alzheimer’s disease, and dementia diagnostics. The book examines different features of EEG signals used to properly diagnose Alzheimer’s Disease early, presenting new and innovative results in the extraction and...
Springer, 2023. — 388 p. — ISBN 978-981-99-2656-5. This book explains the fundamental characteristics and biofunctionality of Alzheimer’s Disease drug targets and provides up-to-date information on the full range of their biomedical applications. An introductory section gives an overview of the recent developments related to drug targets identified and studied related to...
Springer, 2008. — 179 p. — ISSN: 1862-2461, ISBN: 978-3-540-74228-9. DOI 10.1007/978-3-540-74229-6. Therapeutic Approaches for the Treatment of Alzheimer's Disease. Cholinesterase Inhibitors. Beyond Cholesterol: Statin Benefits in Alzheimer's Disease. PPARg Agonists for the Treatment of Alzheimer's Disease. Metal Complexing Agents for the Treatment of Alzheimer's Disease. GSK3...
Springer, 2004 — 254 p.
Almost four decades of innovative and intensive research on Alzheimer’s disease (AD) have brought major advances in our understanding of its pathogenesis, improved tools for diagnosis, and strategies for its treatment. This research has helped build a solid foundation of knowledge in the neurosciences and biological basis of AD and AD-related...
Royal Society of Chemistry, 2010. — 343 p. Emerging Drugs and Targets for Alzheimer's Disease collects some of the most outstanding examples of new drugs currently under pharmaceutical development or new targets in the validation process that will reach the Alzheimer's drug market over the next few years as disease modifying drugs. Written by a team of distinguished experts Volume...
Royal Society of Chemistry, 2010. — 327 p. Alzheimer's disease is the most prevalent neurodegenerative disorder in the elderly. A recent study from the Bloomberg School of Public Health recently estimated that over 26 million people were living with the disease in 2006 and that the global prevalence of the disease will grow to 106 million by 2050. By that time, 43 per cent of...
Wiley, 2019. — 532 p. — ISBN: 978-1-119-35679-0. Understanding the impact of diet, exercise, genetics, and hormones on the risk and development of Alzheimer’s and other neurogenerative diseases Diet is widely known to impact on neurological function. Nevertheless, academic texts discussing this relationship are relatively few in number. This book therefore fills an important...
Springer, 2014. — 43 p. A lot of research on biomarkers for Alzheimer is being done in the last few decades. The aim of these studies is to find some method to ease the diagnosis of Alzheimers as early as possible. Such methods are a range of blood or CSF tests on one hand and several types of neuroimaging scans on the other. Many of the images coming both from laboratory and...
IOS Press, 2017. — 420 p. — (Advances in Alzheimer's Disease 3). Alzheimer’s disease is one of the biggest emerging public health problems in the world. Although the last four decades have yielded important insights into the pathogenesis of Alzheimer’s disease, its cause is still unclear, and if it is not discovered the world will face an unprecedented healthcare problem by the...
McFarland & Company, 2020. — 554 p. — (McFarland Health Topics). — ISBN: 978-1-4766-3891-1. With the recent discovery that amyloid beta protein, the cause of plaques in Alzheimer's disease, is an antimicrobial peptide produced in response to infection, many researchers are focusing on the role infection plays in the development of Alzheimer's disease. Brain studies have also...
Academic Press, 2021. — 254 p. Nearly 44 million people have Alzheimer’s or related dementia worldwide, according to the Alzheimer’s Disease International organization. That number is expected to double every 20 years. Unlike other books on the market, Alzheimer's Disease: Understanding Biomarkers, Big Data, and Therapy covers recent advancements in cognitive, clinical, neural,...
Springer, 2019. — 247 p. This book describes the precise mechanisms by which insulin resistance and diabetes mellitus (DM) act as risk factors for Alzheimer’s disease (AD). It opens by discussing the de novo synthesis of insulin in the brain and its functional significance with regard to glucose metabolism and maintenance of neuronal function in the brain. The epidemiological...
Springer, 2021. — 160 p. — ISBN 978-981-16-6111-2. This book examines writings by people living with Alzheimer's Disease and their caregivers. Its focus areas include the construction of the self in the face of diminishing linguistic and cognitive abilities, the stigmatization of ageing, the various narrative strategies that these texts (often collaborative) employ, the health...
Springer, 2021. — 471 p. — ISBN 978-981-16-6112-9. This book examines writings by people living with Alzheimer's Disease and their caregivers. Its focus areas include the construction of the self in the face of diminishing linguistic and cognitive abilities, the stigmatization of ageing, the various narrative strategies that these texts (often collaborative) employ, the health...
Academic Press, 2019. — 71 p. — ISBN: 978-0-12-816412-9. This book discusses the latest information on recent theranostic avenues for both the diagnosis and treatment of Alzheimer’s patients. It presents the pros and cons of the probable mechanistic role of nanoparticles in crossing the blood-brain barrier and improving disease symptoms. Finally, it highlights the merits of...
Bentham Science Publishers, 2018. — 237 p. — (Recent Advances in Alzheimer Research, Volume 2). — ISBN: 978-1-68108-716-0. Alzheimer’s Disease (AD) is the product of the slow and progressive degenerative alteration that develops in the adult brain and can remain asymptomatic for a considerable time before cognitive deficits becomes evident. The main challenge for researchers is...
Humana, 2024. — 344 p. This fully updated volume provides an up-to-date and comprehensive overview of the current state of technologies helping to accelerate Alzheimer’s disease drug development. Addressing the latest advances in preclinical and clinical research, including new insights into the molecular mechanisms and emerging therapeutic strategies, the book continues by...
CRC Press, 2006. — 199 p. — ISBN: 9781857756371. This is the first book in the field to address the underlying biological abnormalities of Dementia in Alzheimer’s Disease (DAD) in people with Down syndrome. It brings together research findings relating to the neuropathology, genetics, blood markers and neurophysiology of Alzheimer’s disease in older adults with Down syndrome....
World Scientiic Publishing, 2017. — 285 p. — ISBN: 9789813109247. The book aims to present, educate and inform individuals about Alzheimer's disease in a comprehensive manner. Its scope ranges from the discovery of the disease, epidemiology and basic biological principles underlying it, to advanced stem cell therapies used in the treatment of Alzheimer's. It adopts a "global"...
Berlin: Springer, 2008. — 186 p. Permanence of the Synapse and Molecular Instability Cellular Biology of AMPA Receptor Trafficking and Synaptic Plasticity Imaging of Experience-Dependent Structural Plasticity in the Mouse Neocortex in vivo Synapse Loss, Synaptic Plasticity and the Postsynaptic Density Impact of Beta Amyloid on Excitatory Synaptic Transmission and Plasticity...
Springer, 2023. — 460 p. This book illustrates the importance of natural products as the source for the development of novel drugs for the treatment of neurodegenerative disorders, including Alzheimer's disease. It also highlights the role of reactive oxygen species and altered metal homeostasis in the progression of Alzheimer’s disease and examines the potential of...
HarperOne, 2017. — 368 p. — ISBN: 978-0062666475. “The Alzheimer’s Solution, is the best, most professionally informed book of its kind for this much feared disease…the protocol recommended by Drs. Dean and Ayesha Sherzai is a very important message to convey to the public. Please, read this book.” (—T. Colin Campbell, coauthor of The China Study) In this thorough, thoughtful,...
Springer, 2007. — 296 p.
Alzheimer’s Disease: Advances in Genetics, Cellular and Molecular Biology provides exciting, comprehensive and up-to-date summaries of the most important recent advances in the genetic, molecular, biochemical, and cell biological studies of AD. The studies and advances described in this volume will help to accelerate the process of rational drug...
Workman Publishing Company, 2012. — 288 p. Want to keep Alzheimer's at bay for years--ideally, forever? Prevention is the way, and this is the guide. Now in paperback and updated throughout, "The Alzheimer's Prevention Program" is essential for everyone with a family history of Alzheimer's, and for the 80 million baby boomers who worry whenever they forget someone's name. It's...
For Dummies, 2011. — 384 p. An estimated 4 million people are living with Alzheimer’s Disease (AD) in America today, with approximately 370,000 new cases diagnosed every year. AD patients live anywhere from 5 to 20 years after their diagnosis; and their inability to care for themselves grows more dramatic as the disease progresses, creating profound implications for their...
Oxford, UK: Oxford University Press, 2020. — 176 p. — (Very Short Introductions 640). — ISBN13: 9780192559807. As more of us live longer, the fear of an old age devastated by brain diseases like dementia is growing. Many people are already facing the challenges posed by these progressive and terminal conditions, whether in person or because they are caring for loved ones....
Springer, 2023. — 369 p. This book reviews the potential effect of diet modification, lipids, and carbohydrate consumptions, vitamin supplementation, antioxidants, and nutraceuticals in the prevention and management of Alzheimer's disease. The initial chapter of the book presents the pathophysiological mechanisms, risk factors, genetic predisposition, disease diagnosis,...
Bentham Science Publishers, 2017. — 207 p. Frontiers in Clinical Drug Research - Alzheimer Disorders is a book series concerned with Alzheimer's disease (AD) that causes dementia, or loss of brain function. The disease affects the parts of the brain that deal with memory, thought, and language. Chapters in each volume focus on (Alzheimer Disorders) drug research with special...
John Wiley & Sons, 2010. — 286 p. — ISBN: 978-0-470-29342-3. BACE (β-site of APP cleaving enzyme) is a critical component in Alzheimer's Disease (AD), and the development of BACE inhibitors shows great potential as a therapy for the disease. BACE: Lead Target for Orchestrated Therapy of Alzheimer's Disease covers virtually all aspects of BACE from initial identification,...
2nd edition. — Oxford University Press, 2017. — 138 p. — (Oxford Neurology Library). — ISBN: 978–0–19–877980–3. Dementia disorders: an overview Pathophysiology of Alzheimer’s disease Epidemiology of Alzheimer’s disease Clinical course of Alzheimer’s disease Atypical presentations of Alzheimer’s disease Diagnosing Alzheimer’s disease in clinical practice Disclosing the diagnosis...
CRC Press, 2012. — 301 p. — ISBN: 9781439827086. In recent years, a tremendous amount of effort has been focused on better understanding the fundamentals of Alzheimer’s disease (AD) to facilitate early and accurate diagnosis and appropriately targeted therapeutic treatments. Alzheimer’s Disease: Targets for New Clinical, Diagnostic, and Therapeutic Strategies provides a...
Springer, 2024. — 149 p. — ISBN-13 978-3031588105 This book is a compendium of the worldwide studies of Alzheimer’s disease utilizing the eye as a biomarker, or as a treatment method, that are registered with the United States National Institutes of Health website, clinicaltrials.gov. Clinicaltrials.gov is the largest listing of research studies in the world. The study titles...
Academic Press, 2016. — 657 p. — ISBN: 978-0-12-802173-6 Developing Therapeutics for Alzheimer's Disease: Progress and Challenges provides a thorough overview of the latest advances toward the development of therapeutics for Alzheimer’s disease, along with the major hurdles that still must be overcome and potential solutions to these problems. Despite the lack of progress...
Columbia University Press, 2021. — 690 p. — ISBN 978-0-231-55276-9 Alzheimer’s disease, a haunting and harrowing ailment, is one of the world’s most common causes of death. Alzheimer’s lingers for years, with patients’ outward appearance unaffected while their cognitive functions fade away. Patients lose the ability to work and live independently, to remember and recognize....
Columbia University Press, 2021. — 352 p. — ISBN 9780231198707. Alzheimer’s disease, a haunting and harrowing ailment, is one of the world’s most common causes of death. Alzheimer’s lingers for years, with patients’ outward appearance unaffected while their cognitive functions fade away. Patients lose the ability to work and live independently, to remember and recognize. There...
Springer, 2013. — 230 p. — (Caregiving: Research • Practice • Policy) — ISBN: 978-1-4614-5334-5 Assisting someone with Alzheimer’s disease or another illness that causes dementia is incredibly demanding and stressful for the family. Like many disabling conditions, Alzheimer’s disease leads to difficulty or inability to carry out common activities of daily life, and so family...
М.: Эксмо, 2019. — 282 с. Многие из нас знают кого-то, кто пережил рак. Но до настоящего времени мы не знали никого, кто бы смог пережить болезнь Альцгеймера. Долгие годы снижение когнитивных навыков рассматривалось как необратимый процесс. Но в 2017 году группа ученых во главе с доктором Бредесеном произвела революцию в мире медицины, создав протокол лечения этой болезни.
М.: Олимп-Бизнес, 2020. — 242 с. — (Как жить). Если вы либо ваш близкий столкнулись с болезнью Альцгеймера или другими видами деменции, этот краткий справочник поможет вам разобраться, в чем заключаются особенности подобных состояний и как можно помочь больному, себе и своей семье в различных ситуациях. Авторы книги — ведущие эксперты по деменции: психиатр Джеймс Уорнер,...
Комментарии